Population Exposure–Response Efficacy Analysis of Elranatamab (PF-06863135) in Patients with Multiple Myeloma

Authors

Institutions

Publication Details

Journal
Targeted Oncology
Published
2025-08-18
DOI
https://doi.org/10.1007/s11523-025-01168-y
Citations
4
Primary Topic
Multiple Myeloma Research and Treatments
Type
article
Field-Weighted Citation Impact
7.08

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Population Exposure–Response Efficacy Analysis of Elranatamab (PF-06863135) in Patients with Multiple Myeloma

Erik Vandendries, Hoi-Kei Lon, Sibo Jiang, Diane Wang et al.
4 citations
Targeted Oncology
Multiple Myeloma Research and Treatments
7.08
article

Population Exposure–Response Efficacy Analysis of Elranatamab (PF-06863135) in Patients with Multiple Myeloma

Erik Vandendries, Hoi-Kei Lon, Sibo Jiang, Diane Wang, Sharon T. Sullivan, Jennifer Hibma, Athanasia Skoura, Mohamed A. Elmeliegy
article en
4 citations

Abstract

No abstract available for this paper.
Targeted OncologyVol. 20(5)
Pfizer (United States) (US)
Pfizer
Openalex Percentile: Top 3%
Multiple Myeloma Research and Treatments
7.08
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.